Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CAMP4 Therapeutics Corporation - Common Stock
(NQ:
CAMP
)
5.410
+0.030 (+0.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CAMP4 Therapeutics Corporation - Common Stock
CAMP4 to Participate in Upcoming Investor Conferences
March 06, 2026
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
March 05, 2026
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2026
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
December 18, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
December 18, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 14, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
November 06, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
October 01, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
September 10, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
August 14, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
Sequans Appoints Jason W. Cohenour to Board of Directors
June 30, 2025
Paris, France--(Newsfile Corp. - June 30, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading innovator in cellular IoT semiconductor...
Via
Newsfile
CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American
May 16, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights
May 13, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
April 28, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
March 27, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
March 18, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 to Participate in Upcoming Investor Conferences
February 06, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
January 07, 2025
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
December 10, 2024
Industry veterans John Maraganore, Ph.D., and Rachel Meyers, Ph.D., to provide strategic guidance on the company’s RNA Actuating platform to develop a new class of RNA medicines that upregulate protein...
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference
December 02, 2024
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Reports Third Quarter 2024 Financial Results
November 21, 2024
From
CAMP4 Therapeutics
Via
GlobeNewswire
CAMP4 Announces Pricing of Initial Public Offering
October 10, 2024
From
CAMP4 Therapeutics
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
